Stickler syndrome caused by COL2A1 mutations: genotype–phenotype correlation in a series of 100 patients

[1]  M. Passos-Bueno,et al.  Clinical evaluation and COL2A1 gene analysis in 21 Brazilian families with Stickler syndrome: identification of novel mutations, further genotype/phenotype correlation, and its implications for the diagnosis. , 2008, European journal of medical genetics.

[2]  L. Ala‐Kokko,et al.  Missense and nonsense mutations in the alternatively‐spliced exon 2 of COL2A1 cause the ocular variant of Stickler syndrome , 2008, Human mutation.

[3]  John D. Scott,et al.  Missense and silent mutations in COL2A1 result in Stickler syndrome but via different molecular mechanisms , 2007, Human mutation.

[4]  K. Devriendt,et al.  A report on 10 new patients with heterozygous mutations in the COL11A1 gene and a review of genotype–phenotype correlations in type XI collagenopathies , 2007, American journal of medical genetics. Part A.

[5]  J. van den Ende,et al.  A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. , 2006, American journal of human genetics.

[6]  J. Whittaker,et al.  High efficiency of mutation detection in type 1 stickler syndrome using a two‐stage approach: vitreoretinal assessment coupled with exon sequencing for screening COL2A1 , 2006, Human mutation.

[7]  G. Mortier,et al.  The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene , 2005, Journal of Medical Genetics.

[8]  G. Mortier,et al.  Dominant negative mutations in the C‐propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies , 2005, American journal of medical genetics. Part A.

[9]  C. Kielty,et al.  The Collagen Family: Structure, Assembly, and Organization in the Extracellular Matrix , 2003 .

[10]  A. Edwards,et al.  Clinical variability of Stickler syndrome: role of exon 2 of the collagen COL2A1 gene. , 2003, Survey of ophthalmology.

[11]  R. Hofstra,et al.  Occurrence of deletion of a COL2A1 allele as the mutation in Stickler syndrome shows that a collagen type II dosage effect underlies this syndrome , 2002, Human mutation.

[12]  P. Byers,et al.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. , 2002, American journal of human genetics.

[13]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[14]  M. Hentze,et al.  Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway , 2002, Genome Biology.

[15]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.

[16]  G. Stickler,et al.  Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): A survey , 2001, Genetics in medicine : official journal of the American College of Medical Genetics.

[17]  P. Harper,et al.  Variation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helix. , 2000, American journal of human genetics.

[18]  J. Yates,et al.  COL2A1 exon 2 mutations: relevance to the Stickler and Wagner syndromes , 2000, The British journal of ophthalmology.

[19]  P. Byers,et al.  Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. , 1999, American journal of human genetics.

[20]  J. Yates,et al.  Clinical and molecular genetics of Stickler syndrome , 1999, Journal of medical genetics.

[21]  A. Laupacis,et al.  Clinical prediction rules. A review and suggested modifications of methodological standards. , 1997, JAMA.

[22]  J. Yates,et al.  A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. , 1996, Human molecular genetics.

[23]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[24]  D. Rimoin,et al.  Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type , 1995, Nature Genetics.

[25]  K. Cheah,et al.  Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus , 1995, Cell.

[26]  D. Rimoin,et al.  A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia. , 1994, Human molecular genetics.

[27]  A. Winterpacht,et al.  The type II collagenopathies: A spectrum of chondrodysplasias , 1994, European Journal of Pediatrics.

[28]  D J Prockop,et al.  Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Tasman,et al.  Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D J Spiegelhalter,et al.  Probabilistic prediction in patient management and clinical trials. , 1986, Statistics in medicine.

[32]  Steinberg Ag,et al.  Hereditary progressive arthro-ophthalmopathy , 1965 .

[33]  F. J. Farrell,et al.  HEREDITARY PROGRESSIVE ARTHRO-OPHTHALMOPATHY. , 1965, Mayo Clinic proceedings.